Ahrendt, D. (2001). Ergogenic Aids: Counseling the Athlete. Am Fam Physician, 63,913-22.
Alba-Roth, J., Muller, O.A., Schopohl, J. & Von Werder, K. (1998). Arginine stimulatesgrowth hormone secretion
by suppressing endogenous soma-tostatin secretion. J Clin Endocrinol Metab, 67(6), 1186-9.
Anderson, S. & Raiten, D. (1992). Safety of amino acids used as dietary supp¬lements: Life Sciences Research Office, FDA Contract No. 223-88¬2124.117-125.
Balon, T. & Nadler, J. (1994). Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol, 77,2519-21.
Balon, T. & Nadler, J. (1997). Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol, 82,359-363.
Barbul, A. (1986). "Arginine: Biochemistry, physiology, and therapeutic implications." J Parenter Enteral Nutr, 10(2), 227-38.
Bednarz, B., Jaxa-Chamiec, T., Gebalska, J., Herbaczynska-Cedro, K. & Ceremuzynski, L. (2004). L-arginine supplementation prolongs duration of exercise in congestive heart failu-re. Pol Heart J, 60(4), 348-53.
Bednarz, B.,Jaxa-Chamiec, T., Maciejewski, P., Szpajer, M., Janik, K., Gniot, J., Kawka-Urbanek.T. Drozdowska, D. Gessek, J. & Laskowski, H. (2005). Efficacy and safety of oral L-arginine in acute myo¬cardial infarction. Results of multi-center randomized, double- blind, p¬lacebo-controlled ARAM I pilot trial. Kardiol Pol, 62,421-6
Boger, R.H. & Bode-Boger, S.M. (2001). The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol, 41,79-99.
Bucci, L. (1993). Nutrients as Ergogenic Aids for Sports and Exercise. Wolinsky, I. & Hickson, J.F (eds). Nutrition and the Strength Athlete, Boca Raton, CRC Press.
Buford, B.N. & Koch, A.J. (2004) Glycine-arginine-alpha-ketoisocaproic acid improves performance of repeated cycling sprints. Med Sci Sports Exerc, 36,583-587.
Burtscher, M., Brunner, F., Faulhaber, M., Hotter, B. & Rudolf, L. (2005). The prolonged intake of L-arginine L-aspartate reduces blood lactate ac¬cumulation and oxygen consumption during submaximal exercise. J Sport Sci Med, 4,314-322.
Campbell, B., La Bounty, P. & Roberts, M. (2004). The Ergogenic Potential of Ar¬ginine. J IntSoc Sport Nut, 1(2),35¬38.
Campbell, B., Roberts, M., B.S., Kerksick, C.& Wilborn, C. (2006). Pharmaco¬kinetics, safety, and effects on exer¬cise performance of L-arginine alfa-ketoglutarate in trained adult men. Nutrition,22,872-881.
Ceremuzynski,L. Chamiec.T. & Herbacynska-Cedro, K.(1997). Effect on supplemental oral L-arginine exer¬cise capacity in patients with stable angina pectoris. Am J Cardiol, 80, 331-33.
Champe, P.C. & Harvey, R.A. (1994). Biochemistry, J.B. Lippincott Company: Philadelphia, Chen, J., Wollman, Y, Chernichovsky.T., laina, A, Sofer, M. & Matzkin, H. (1999). Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunc¬tion: results of a double-blind, randomized, placebo-controlled Study. BJU Int, 83(3), 269-73.
Cheng, J.W. & Balwin, S.N. (2001). L-arginine in the management of car-diovascular diseases. Ann Pharma-cother, 35,755-64.
Colombani, P.C., Bitzi, R., Frey-Rindova, P., Frey, W., Arnold,M., Langhans, W. & Wenk, C. (1999). Chronic arginine aspartate supplementation in
runners reduces total plasma amino acid level at rest and during a marathon run. Eur J Nutr, 38,263-70.
Cooke, J.P.&Tsao, P.S. (1997). Arginine: A new therapy for atherosclerosis? Circulation, 95,311-312.
Creager, M.A., Gallagher, S.J., Girerd, X.J., Coleman, S.M., Dzau, V.J. & Cooke, J.P. (1992). L-arginine im-proves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest, 90,1248-53.
Doutreleau, S., Mettauer, B., Piquard, R, Schaefer.A., Lonsdorfer.E., Richard, R. & Geny, B. (2005). Chronic but not acute oral L-arginine supplementati-on delays the ventilatory threshold during exercise in heart failure pati-ents. Can J Appl Physiol,30(4),419-432.
Doutreleau, S., Mettauer, B., Piquard, R, Rouyer, O., Schaefer.A., Lonsdorfer, J. & Geny, B. (2006). Chronic L- argi¬nine supplementation enhances en¬durance exercise tolerance in heart failure patients. Int J Sports Med, 27(7),567-72.
Esplugues, J.V. (2002). NO as a signalling molecule in the nervous system. Brit J Pharmacol, 135,1079 -1095.
Fisker, S., Nielsen, S., Ebdrup, L., Bech, J.N., Christiansen, J.S., Pedersen, E.B. & Jorgensen, J.O. (1999a). The role of nitric oxide in L-arginine stimu¬lated growth hormone release. J En¬docrinol Invest, 22, 89-93.
Fisker, S., Nielsen, S., Ebdrup, L., Bech, J.N., Christiansen, J.S., Pedersen, E. B. & Jorgensen, J.O. (1999 b). L-argi-
nine-induced growth hormone sec¬retion is not influenced by coinfusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine in healthy men. Growth Horm IGF Res 9,69-73.
Flakoll,P.,Sharp,R.,Baier,S.,Levenhagen, D., Carr, C. & Nissen,S.(2004). Effect of beta-hyd roxy-betamethy I buty rate, arginine, and lysine supplementation on strength, functionality, body com¬position, and protein metabolism in-elderly women. Nutrition, 20,445-51. Giugliano, D., Marfella, R., Verrazzo, G., Acampora.R.,Coppola,L.&Cozzolino D.(1997). The vascular effects of L-arginine in humans. J Clin lnvest,99, 433-438.
Green, S.J., Mellouk.S. & Hoffman, S.L. (1990).Cellular mechanisms of non-specific immunity to intracellular in-fection: cytokine induced synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytes. Immunol Lett, 25(1-3), 15-9.
Gremion.G., Palud.P. &Gobelet,C. (1989). Arginine aspartate and muscular acti¬vity. Parti I. SchweizerZeitschriftfur Sportmedizin, 37,241-246.
Hurson, M., Regan M.C., Kirk, S.J., Wasserkrug, H.L. & Barbul, A. (1995). Metabolic effects of arginine in a healthy elderly population. J parenter Enteral Nutr, 19(3), 227-30.
Huynh, NT. & Tayek, J.A. (2002). Oral arginine reduces systemic blood pressure in type 2 diabetes: Its po-tential role in nitric oxide generation. J Am Coll Nutri, 21 (5),422-7.
Isidori.A., Monaco A.L. & Cappa, M. (1981). A study of growth hormone release in man after oral administra-tion of amino acids. Curr Med Re-search and Opinion, 7(7), 475-481.
Juhn, M.S. & Tarnopolsky, M. (1998). Oral creatine supplementation and athle¬tic performance: Acritical review. Clin J Sport Med, 8,286 -297.
Kindig, C.A., McDonough, P., Erickson, H. H. & Poole, D.C. (2001). Effect of L-NAME on oxygen uptake kinetics during heavy-intensity exercise in the horse. J Appl Physiol, 91,891-96.
Kirk, S.J, Hurson, M., Regan, M.C., Holt,
D.R., Wasserkrug, H.L. & Barbul, A. (1993).Arginine stimulates wound he¬aling and immune function in elderly human beings. Surgery,114(2),155-9.
Lambert, M.I., Hefer, J.A., Millar, R.P. & Macfarlane, P.W. (1993). Failure of commercial oral amino acid supple-ments to increase serum growth hor¬mone concentrations in male body¬builders. Int J Sport Nutr,3,298-305.
Lawrence, M., & Kirby, D. (2002). Nutrition and sports supplements: Fact or fiction. J Clin Gastro, 35,299-306.
Lin, W.T., Yang, S.C., Tsai, S.C., Huang, C.C. & Lee, N.Y (2006). L-Arginine attenuates xanthine oxidase and m-yeloperoxidase activities in hearts of rats during exhaustive exercise. Brit J Nut, 95(1), 67-75.
Maccario, M., Procopio, M., Loche, S., Cappa, M., Martina, V., Camanni, F. & Ghigo, E. (1994). Interaction of free fatty acids and arginine on growth hormone secretion in man. Metabo¬lism, 43,223-226.
Marcell, T.J., Taaffe, D.R., Hawkins, S.A., Tarpenning, K.M., Pyka, G., Kohlmeier.L., Wiswell,R.A.& Marcus, R.(1999). Oral arginine does not sti-mulate basal or augment exercise -induced GH secretion in either young or old adults. J Gerontol A Biol Sci MedSci, 54,395-399.
Maxwell, A.J., Ho, H.V., Le, C.Q., Lin, P.S., Bernstein.D. & Cooke, J.P.(2001). L-arginine enhances aerobic exercise capacity in association with augmen¬ted nitric oxide production. J Appl Physiol, 90, 933-938.
Merimee, T.J., Rabinowitz, D., Riggs, L., Burgess, J.A., Rimoin, D. L. & Mc Kusick.V.A. (1967). Plasma growth hormone after arginine infusion. Cli-nical experiences. N Engl J M e d , 276,434-439.
Merimee, T.J., Rabinowitz, D. & Fineberg,
S.E. (1969). Arginine-initiated release of human growth hormone:factors modifying the response in normal man. N Engl J Med, 280,1434-1438.
Mills, P.C., Marlin, D.J., Scott, CM. & Smith, N.C. (1999). Metabolic effects of nitric oxide synthase inhibition dur¬ing exercise in the horse. Res Vet Sci, 66,135-138.
Mohr, S., Stamler, J.S. & Brune, B. (1996). Posttranslational modification of gly-ceraldehyde- 3 -phosphate dehydro¬genase by S-nitrosylation and sub¬sequent NAD H attachment. J Biol Chem,271, 4209-4214.
Morris, C. R., Morris, S.M., Hagar, W., Van Warmerdam J., Claster, S., Kepka -Lenhart, D., Machado, L., Kuypers.F. A. & Vichinsky, E.P. (2003). Arginine therapy: A new therapy for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med, 168(1), 63-69.
Mùhling, J., Fuchs, M., Fleck, C, Sablotzki.A., Krùll, M., Dehne, M.G., Gonter, J., Weiss, S., Engel, J. & Hempelmann, G. (2002). Effects of arginine, L- alanyl L-glutamine or tau¬rine on neutrophil (PMN) free amino acid profiles and immune functions in vitro. Amino Acids, 22(1 ),39-53.
Nagaya, N., Uematsu, M., Oya, H., Sato N, Sakamaki, F., Kyotani, S., Ueno, K., Nakanishi, N., Ymagishi, M. & Miyatake, K. (2001). Short-term oral administration of L-arginine improves hemodynamics and exercise capa¬city in patients with precapillary pul¬monary hypertension. Am J Res-pir Crit Care Med, 163,887-91.
Nielsen, H.B., Clemmesen, J.O., Skak, C, Ott, P. & Scher, N.H. (2002). Attenu-ated hepatosplanchnic uptake of lac¬tate during intense exercise in hu¬mans. J Appl Physiol, 92(4), 1677¬1683.
Oomen, CM., van Erk, M.J., Feskens, E.J., Kok, F.J. & Kromhout, D. (2000). Arginine intake and risk of coronary heart disease mortality in elderly men. Arterioscler Thromb Vase Biol,20(9), 2134-2139.
Paddon-Jones, D., Borsheim, E. & Wolfe, R.R.(2004). Potential ergogenic ef¬fects of arginine and creatine supp-lementation.J Nutr, 134.2888S2894S.
Palmer, J.P., Walter, R.M. & Ensinck, J.W. (1975). Arginine-stimulated acute phase of insulin and glucagon sec¬retion. I. in normal man. Diabetes, 24,735-740.
Palmer, R.M., Ferrige,A.G. & Moneada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327(6122), 524-526.
Reíd, M.B. (1998). Role of nitric oxide in skeletal muscle: synthesis, distri-bution and functional importance. Acta Physiol Scan, 162,401-409.
Reiser, P.J., Kline, W.O. & Vaghy, P.L. (1997). Induction of neuronal type nitric oxide synthase in skeletal muscle by chronic electrical stimu-lation in vivo. J Appl Physiol, 82, 1250-1255
Saitoh, S., & Suzuki, M. (1986). Nutritional design for repletion of liver and muscle glycogen during endurance exercise without inhibiting lipolysis. J NutrSciVitaminol, 32,343-353.
Sales, R.P., César Miné, CE., Franco, A. D. & Rodrigues, E.L. (2005). Effects of the acute arginine aspartate supp¬lement on the muscular fatigue in trained volunteers, Rev Bras Med Esporte, 11 (6), 347-351.
Santos, R.S., Pacheco, M.T., Martins, R., Villaverde, A.B., Giana, H.E., Baptista, F. & Zangara, R.A. (2002). Study of the effect of oral adminis-tration of L-arginine on muscular per¬formance in healthy volunteers: an isokinetic study. Isokinet Exerc Sci,
10,153-8.
Schaefer, A., Piquard, F., Geny, B., Doutreleau, S., Lampert, E., Mettauer, B. & Lonsdorfer, J. (2002). L-Arginine reduces exercise-induced increase in plasma lactate and am-monia. Int J Sports Med, 23,403-407.
Stamler, J.S. & Meissner, G. (2001). Phy¬siology of nitric oxide in skeletal muscle. Physiol Rev, 81(1), 209-237.
Stead, L.M., Au, K.P., Jacobs, R.L., Brosnan, M.E. & Brosnan, J.T.(2001). Methylation demand and homo¬cysteine metabolism: effects of die¬tary provision of creatine and guanidi-neacetate. Am J Physiol, 281,E1095 -E1100.
Suminski, R.R. (1997). Acute effect of amino acid ingestion and resistance exercise on plasma growth hormone concentrations in young men. Int J Sport Nutr, 7(1), 48-60.
Swanson, B., Keithley, J.K., Zeller, J.M. & Sha, B.E. (2002). A pilot study of the safety and efficacy of supplemental arginine to enhance immune functi¬on in persons with HIV/AIDS. Nutrition, 18(7-8), 688-690.
Tachibana, K., Mukai, K. Hiraoka, I., Moriguchi, S.,Takama, S. & Kishino, Y. (1985). Evaluation of the effect of arginine-enriched amino acid solu-tion on tumor growth. J Parenter Enteral Nutr, 9(4), 428-434.
Thomas, G.D. & Victor, R.G. (1998). Nitric oxide mediates contraction- induced attenuation of sympathetic vaso¬constriction in rat skeletal muscle. J Physiol, 506,817-826.
Tong, B.& Barbul, A. (2004). Cellular and Physiological Effects of Arginine. Mini-Rev Med Chem, 4,823-832.
Vandenberghe, K., Goris, M., Van Hecke, P., Van Leemputte, M., Vangerven, L.
&Hespel, P. (1997). Long-term crea-tine intake is beneficial to muscle performance and pharmacokinetic considerations. J Appl Physiol, 83, 2055-2063.
Van Haeften, T.W., Voetberg, G.A., Gerich, J.E. & van der Veen, E.A. (1989). Dose response charac-teristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia. J Clin Endocrinol Metab, 69,1059-64.
Visek, W.J. (1986). Arginine needs phy-siological state and usual diets: A réévaluation. J Nutr, 116, 36-46.
VolekJ.S., Duncan N.D., Mazzetti S.A. & Putukian M.(1999). Performance and muscle fiber adaptations to creatine supplementation and heavy resistan¬ce training. Med Sci Sports Exerc, 31,1147-1156.
Volpi, E., Kobayashi, H., Sheffield-Moore, M., Mittendorfer, B. & Wolfe, R.R. (2003) Essential amino acids stimu¬late muscle protein anabolism in healthy older adults regardless of the presence of non-essential amino a¬cids. Am J Clin Nutr, 78,250-258.
Walberg-Rankin, J., Hawkins, C, Fild, D. & Sebolt, D. (1994). The effect of oral
arginine during energy restriction in male weight trainers. J Strength Cond Res, 8(3), 170-177.
Walker, J.B. (1979). Creatine:biosynthe-sis, regulation,and function. Adv Enzymol Relat Areas Mol Biol, 50, 177-242.
Weidenbach, H., Nussler, A.K., Shu, Z., Adler, G. & Beckh, K. (1997). Nitric oxide formation lowers norepine-phrine-induced intrahepatic resistan¬ce without major effects on the me¬tabolism in the perfused rat liver. Hepatology, 26(1), 147-54.
Wells, B.J., Mainous, A.G. & Everett, C.J. (2005) Association between dietary arginine and C-reactive protein. Nut-rition, 121(2), 125-130.
Wolin, M.S., Hintze, T.H., Shen, W., Mohazzab-H, K.M.& Xie.Y.W. (1997). Involvement of reactive oxygen and nitrogen species in signaling mec-hanisms that control tissue respira-tion in muscle. Biochemical So¬ciety Transactions, 25(3), 934-39.
Wolinsky, I. & Hickson, J.F. (1998). Nutrition in Exercise and Sport, Second Edition. Nutrition and the Strength Athlete,
Wolinsky I. & Hickson J. F.. Boca Raton, CRC Press. Wu, G. & Morris, S.M. (1998). Arginine metabolism: Nitric oxide and beyond. Biochem J, 336(1), 1-17.
Thank you for copying data from http://www.arastirmax.com